DEREK J MAETZOLD

CIK 1239501 · Pres. & Chief Exec. Officer · last filed 2026-06-03

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.34M

Companies

2

Total Filings

189

Lifetime Open-Market Net

-$91.13M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CSTL Pres. & Chief Exec. Officer 64,601 $20.70 $1.34M -$91.13M 185 2026-06-03
ENCYSIVE PHARMACEUTICALS INC (ENCY) Delisted V.P., Marketing & Sales 0 $0 4 2008-04-03

Recent Filings · Page 19 of 19

189 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2020-05-26 CSTL Sell (S) −5,000 -$184.9K EDGAR
2020-05-18 CSTL Sell (S) −10,000 -$325.8K EDGAR
2020-05-14 CSTL Exer (M) +65,627 $126.0K EDGAR
2019-12-17 CSTL Grant (A) $0 EDGAR
2019-07-31 CSTL Conv (C) +95,362 $103.7K EDGAR
2008-04-03 ENCYSIVE PHARMACEUTICALS INC (ENCY) Delisted U −172,895 -$406.3K EDGAR
2008-01-15 ENCYSIVE PHARMACEUTICALS INC (ENCY) Delisted Grant (A) +100,000 $0 EDGAR
2007-12-13 ENCYSIVE PHARMACEUTICALS INC (ENCY) Delisted Grant (A) +50,000 $0 EDGAR
2007-03-16 ENCYSIVE PHARMACEUTICALS INC (ENCY) Delisted Grant (A) +30,218 $0 EDGAR
Showing 181189 of 189
Page 19 of 19
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.